• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神分裂症早期的突触末梢密度:SV2A 的 UCB-J 正电子发射断层扫描研究。

Synaptic Terminal Density Early in the Course of Schizophrenia: An In Vivo UCB-J Positron Emission Tomographic Imaging Study of SV2A.

机构信息

Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom; Psychiatric Imaging Group, Medical Research Council, London Institute of Medical Sciences, Hammersmith Hospital, London, United Kingdom; Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom; Centre for Psychiatry and Mental Health, Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom.

Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom; Psychiatric Imaging Group, Medical Research Council, London Institute of Medical Sciences, Hammersmith Hospital, London, United Kingdom; Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.

出版信息

Biol Psychiatry. 2024 Apr 1;95(7):639-646. doi: 10.1016/j.biopsych.2023.05.022. Epub 2023 Jun 15.

DOI:10.1016/j.biopsych.2023.05.022
PMID:37330164
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10923626/
Abstract

BACKGROUND

The synaptic hypothesis is an influential theory of the pathoetiology of schizophrenia (SCZ), which is supported by the finding that there is lower uptake of the synaptic terminal density marker [C]UCB-J in patients with chronic SCZ than in control participants. However, it is unclear whether these differences are present early in the illness. To address this, we investigated [C]UCB-J volume of distribution (V) in antipsychotic-naïve/free patients with SCZ who were recruited from first-episode services compared with healthy volunteers.

METHODS

Forty-two volunteers (SCZ n = 21, healthy volunteers n = 21) underwent [C]UCB-J positron emission tomography to index [C]UCB-J V and distribution volume ratio in the anterior cingulate, frontal, and dorsolateral prefrontal cortices; the temporal, parietal and occipital lobes; and the hippocampus, thalamus, and amygdala. Symptom severity was assessed in the SCZ group using the Positive and Negative Syndrome Scale.

RESULTS

We found no significant effects of group on [C]UCB-J V or distribution volume ratio in most regions of interest (effect sizes from d = 0.0-0.7, p > .05), with two exceptions: we found lower distribution volume ratio in the temporal lobe (d = 0.7, uncorrected p < .05) and lower V/f in the anterior cingulate cortex in patients (d = 0.7, uncorrected p < .05). The Positive and Negative Syndrome Scale total score was negatively associated with [C]UCB-J V in the hippocampus in the SCZ group (r = -0.48, p = .03).

CONCLUSIONS

These findings indicate that large differences in synaptic terminal density are not present early in SCZ, although there may be more subtle effects. When taken together with previous evidence of lower [C]UCB-J V in patients with chronic illness, this may indicate synaptic density changes during the course of SCZ.

摘要

背景

突触假说(synaptic hypothesis)是精神分裂症(schizophrenia,SCZ)病理生理学的一个有影响力的理论,该理论得到了这样的发现的支持,即与对照组参与者相比,患有慢性 SCZ 的患者突触末梢密度标志物[C]UCB-J 的摄取较低。然而,目前尚不清楚这些差异是否在疾病早期存在。为了解决这个问题,我们调查了来自首发服务的抗精神病药物初治/无药物治疗的 SCZ 患者与健康志愿者相比,[C]UCB-J 分布容积(V)。

方法

42 名志愿者(SCZ n=21,健康志愿者 n=21)接受[C]UCB-J 正电子发射断层扫描,以标记前扣带回、额和背外侧前额皮质、颞叶、顶叶和枕叶以及海马体、丘脑和杏仁核中的[C]UCB-J V 和分布容积比。SCZ 组的症状严重程度使用阳性和阴性综合征量表进行评估。

结果

我们发现,在大多数感兴趣的区域(效应大小从 d=0.0-0.7,p>.05),组间对[C]UCB-J V 或分布容积比没有显著影响,只有两个例外:我们发现颞叶的分布容积比(d=0.7,未校正 p<0.05)和前扣带回皮质的 V/f 较低(未校正 p<0.05)。SCZ 组的正、阴性综合征量表总分与海马体中的[C]UCB-J V 呈负相关(r=-0.48,p=0.03)。

结论

这些发现表明,在 SCZ 早期,突触末梢密度的差异并不明显,尽管可能存在更微妙的影响。当与先前慢性疾病患者[C]UCB-J V 较低的证据结合起来时,这可能表明在 SCZ 过程中突触密度发生了变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8aa/10923626/b11b5a0fb514/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8aa/10923626/c769bab047c6/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8aa/10923626/24e5556a343e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8aa/10923626/b11b5a0fb514/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8aa/10923626/c769bab047c6/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8aa/10923626/24e5556a343e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8aa/10923626/b11b5a0fb514/gr3.jpg

相似文献

1
Synaptic Terminal Density Early in the Course of Schizophrenia: An In Vivo UCB-J Positron Emission Tomographic Imaging Study of SV2A.精神分裂症早期的突触末梢密度:SV2A 的 UCB-J 正电子发射断层扫描研究。
Biol Psychiatry. 2024 Apr 1;95(7):639-646. doi: 10.1016/j.biopsych.2023.05.022. Epub 2023 Jun 15.
2
Exploring the influence of synaptic density and anxiety on pain perception: evidence from a [11C]UCB-J positron emission tomography imaging study.探索突触密度和焦虑对疼痛感知的影响:来自一项[11C]UCB-J正电子发射断层扫描成像研究的证据。
Int J Neuropsychopharmacol. 2025 Jul 23;28(7). doi: 10.1093/ijnp/pyaf040.
3
C-UCB-J PET imaging is consistent with lower synaptic density in autistic adults.C-UCB-J正电子发射断层显像与自闭症成年患者较低的突触密度相符。
Mol Psychiatry. 2025 Apr;30(4):1610-1616. doi: 10.1038/s41380-024-02776-2. Epub 2024 Oct 4.
4
First-in-Human Evaluation of F-SynVesT-1, a Radioligand for PET Imaging of Synaptic Vesicle Glycoprotein 2A.人源化 F-SynVesT-1 的首次临床评估,一种用于突触囊泡糖蛋白 2A 的 PET 成像放射性配体。
J Nucl Med. 2021 Apr;62(4):561-567. doi: 10.2967/jnumed.120.249144. Epub 2020 Aug 28.
5
Synaptic Density in Multiple Sclerosis: An In Vivo Study Using [C]UCB-J-PET Imaging.多发性硬化症中的突触密度:一项使用[C]UCB-J正电子发射断层扫描成像的体内研究。
Neurol Neuroimmunol Neuroinflamm. 2025 Sep;12(5):e200435. doi: 10.1212/NXI.0000000000200435. Epub 2025 Jul 3.
6
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
7
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
8
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
9
In vivo evidence of lower synaptic vesicle density in schizophrenia.精神分裂症中突触囊泡密度降低的体内证据。
Mol Psychiatry. 2021 Dec;26(12):7690-7698. doi: 10.1038/s41380-021-01184-0. Epub 2021 Jun 16.
10
Positron emission tomography-adapted therapy for first-line treatment in individuals with Hodgkin lymphoma.正电子发射断层扫描适配疗法用于霍奇金淋巴瘤患者的一线治疗
Cochrane Database Syst Rev. 2015 Jan 9;1(1):CD010533. doi: 10.1002/14651858.CD010533.pub2.

引用本文的文献

1
Network-based Molecular Constraints on Synaptic Density Alterations in Schizophrenia.基于网络的精神分裂症突触密度改变的分子制约因素
medRxiv. 2025 Mar 23:2025.03.22.25324465. doi: 10.1101/2025.03.22.25324465.
2
Generating synthetic brain PET images of synaptic density based on MR T1 images using deep learning.利用深度学习基于磁共振T1图像生成突触密度的合成脑正电子发射断层扫描(PET)图像。
EJNMMI Phys. 2025 Mar 31;12(1):30. doi: 10.1186/s40658-025-00744-5.
3
The relationship between cortical synaptic terminal density marker SV2A and glutamate early in the course of schizophrenia: a multimodal PET and MRS imaging study.

本文引用的文献

1
The synaptic hypothesis of schizophrenia version III: a master mechanism.精神分裂症的突触假说 III:主控机制
Mol Psychiatry. 2023 May;28(5):1843-1856. doi: 10.1038/s41380-023-02043-w. Epub 2023 Apr 11.
2
Neuroimaging in schizophrenia: an overview of findings and their implications for synaptic changes.精神分裂症的神经影像学:研究结果概述及其对突触变化的影响。
Neuropsychopharmacology. 2023 Jan;48(1):151-167. doi: 10.1038/s41386-022-01426-x. Epub 2022 Sep 2.
3
Integrating the Neurodevelopmental and Dopamine Hypotheses of Schizophrenia and the Role of Cortical Excitation-Inhibition Balance.
精神分裂症病程早期皮质突触终末密度标志物SV2A与谷氨酸之间的关系:一项多模态PET和MRS成像研究
Transl Psychiatry. 2025 Mar 1;15(1):70. doi: 10.1038/s41398-025-03269-8.
4
The relationship between SV2A levels, neural activity, and cognitive function in healthy humans: A [11C]UCB-J PET and fMRI study.健康人群中突触囊泡蛋白2A(SV2A)水平、神经活动与认知功能之间的关系:一项[11C]UCB-J正电子发射断层扫描(PET)和功能磁共振成像(fMRI)研究。
Imaging Neurosci (Camb). 2024 Jun 10;2:1-16. doi: 10.1162/imag_a_00190. eCollection 2024 Jun 1.
5
EANM perspective on clinical PET and SPECT imaging in schizophrenia-spectrum disorders: a systematic review of longitudinal studies.欧洲核医学与分子影像学会关于精神分裂症谱系障碍临床正电子发射断层显像(PET)和单光子发射计算机断层显像(SPECT)成像的观点:纵向研究的系统评价
Eur J Nucl Med Mol Imaging. 2025 Feb;52(3):876-899. doi: 10.1007/s00259-024-06987-1. Epub 2024 Nov 22.
6
Synaptic Density in Early Stages of Psychosis and Clinical High Risk.精神病早期阶段及临床高危状态下的突触密度
JAMA Psychiatry. 2025 Feb 1;82(2):171-180. doi: 10.1001/jamapsychiatry.2024.3608.
7
Synaptic changes in psychiatric and neurological disorders: state-of-the art of in vivo imaging.精神神经疾病的突触变化:活体成像的最新技术。
Neuropsychopharmacology. 2024 Nov;50(1):164-183. doi: 10.1038/s41386-024-01943-x. Epub 2024 Aug 12.
8
A systematic review and meta-analysis of neuroimaging studies examining synaptic density in individuals with psychotic spectrum disorders.对精神分裂症谱系障碍个体的突触密度进行的神经影像学研究的系统回顾和荟萃分析。
BMC Psychiatry. 2024 Jun 19;24(1):460. doi: 10.1186/s12888-024-05788-y.
整合精神分裂症的神经发育和多巴胺假说以及皮质兴奋-抑制平衡的作用。
Biol Psychiatry. 2022 Sep 15;92(6):501-513. doi: 10.1016/j.biopsych.2022.06.017. Epub 2022 Jun 22.
4
Incomplete Hippocampal Inversion: A Neurodevelopmental Mechanism for Hippocampal Shape Deformation in Schizophrenia.不完全海马回反转:精神分裂症中海马形状变形的神经发育机制。
Biol Psychiatry. 2022 Aug 15;92(4):314-322. doi: 10.1016/j.biopsych.2022.02.954. Epub 2022 Feb 23.
5
Prenatal interleukin 6 elevation increases glutamatergic synapse density and disrupts hippocampal connectivity in offspring.产前白细胞介素 6 水平升高会增加谷氨酸能突触密度,并破坏后代海马体的连接。
Immunity. 2021 Nov 9;54(11):2611-2631.e8. doi: 10.1016/j.immuni.2021.10.006.
6
The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study.健康志愿者中突触密度标志物 SV2A 与谷氨酸和 N-乙酰天门冬氨酸水平的关系:一项多模态 PET 和磁共振波谱脑成像研究。
Transl Psychiatry. 2021 Jul 17;11(1):393. doi: 10.1038/s41398-021-01515-3.
7
In vivo evidence of lower synaptic vesicle density in schizophrenia.精神分裂症中突触囊泡密度降低的体内证据。
Mol Psychiatry. 2021 Dec;26(12):7690-7698. doi: 10.1038/s41380-021-01184-0. Epub 2021 Jun 16.
8
Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats.突触密度标志物 SV2A 在精神分裂症患者中减少,而在大鼠中不受抗精神病药物影响。
Nat Commun. 2020 Jan 14;11(1):246. doi: 10.1038/s41467-019-14122-0.
9
Assessment of a white matter reference region for C-UCB-J PET quantification.评估 C-UCB-J PET 定量的白质参考区域。
J Cereb Blood Flow Metab. 2020 Sep;40(9):1890-1901. doi: 10.1177/0271678X19879230. Epub 2019 Sep 30.
10
Characterization of 3 PET Tracers for Quantification of Mitochondrial and Synaptic Function in Healthy Human Brain: F-BCPP-EF, C-SA-4503, and C-UCB-J.用于量化健康人脑线粒体和突触功能的 3 种 PET 示踪剂的特征:F-BCPP-EF、C-SA-4503 和 C-UCB-J。
J Nucl Med. 2020 Jan;61(1):96-103. doi: 10.2967/jnumed.119.228080. Epub 2019 Jul 19.